CBOA
TMO icon

Commonwealth Bank of Australia’s Thermo Fisher Scientific TMO Stock Holding History

Commonwealth Bank of Australia’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-18,229
Closed -$5.35M – 865
2019
Q2 		$5.35M Sell
18,229
-686
-4% -$189K 0.05% 220
2019
Q1 		$5.17M Sell
18,915
-2,000
-10% -$498K 0.05% 222
2018
Q4 		$4.68M Sell
20,915
-666
-3% -$156K 0.05% 215
2018
Q3 		$5.26M Sell
21,581
-100
-0.5% -$23K 0.05% 222
2018
Q2 		$4.48M Buy
21,681
+206
+1% +$43.7K 0.04% 233
2018
Q1 		$4.43M Sell
21,475
-3,050
-12% -$640K 0.05% 227
2017
Q4 		$4.65M Sell
24,525
-509
-2% -$97.5K 0.05% 244
2017
Q3 		$4.73M Buy
25,034
+490
+2% +$88.7K 0.05% 237
2017
Q2 		$4.28M Buy
24,544
+1,619
+7% +$272K 0.04% 234
2017
Q1 		$3.52M Buy
22,925
+1,443
+7% +$221K 0.04% 257
2016
Q4 		$3.03M Buy
21,482
+1,394
+7% +$206K 0.04% 272
2016
Q3 		$3.19M Sell
20,088
-800
-4% -$123K 0.04% 251
2016
Q2 		$3.09M Buy
20,888
+380
+2% +$56.1K 0.04% 253
2016
Q1 		$2.9M Sell
20,508
-53
-0.3% -$7.1K 0.04% 264
2015
Q4 		$2.92M Sell
20,561
-3,050
-13% -$407K 0.04% 247
2015
Q3 		$2.89M Sell
23,611
-682
-3% -$88.9K 0.04% 243
2015
Q2 		$3.15M Sell
24,293
-144
-0.6% -$18.8K 0.04% 211
2015
Q1 		$3.28M Buy
24,437
+400
+2% +$51.6K 0.04% 213
2014
Q4 		$3.01M Sell
24,037
-5,494
-19% -$668K 0.04% 214
2014
Q3 		$3.59M Buy
29,531
+100
+0.3% +$12.2K 0.05% 215
2014
Q2 		$3.47M Sell
29,431
-127,997
-81% -$15.1M 0.05% 219
2014
Q1 		$18.9M Buy
157,428
+21,116
+15% +$2.51M 0.12% 178
2013
Q4 		$15.2M Buy
136,312
+14,862
+12% +$1.48M 0.1% 201
2013
Q3 		$11.2M Buy
121,450
+10,661
+10% +$964K 0.08% 230
2013
Q2 		$9.38M Buy
+110,789
New +$9.22M 0.07% 251

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Commonwealth Bank of Australia's TMO Position: Q3 2019 in Review

Commonwealth Bank of Australia sold out of Thermo Fisher Scientific (TMO) in Q3 2019, closing a stake of 18,229 shares — an estimated $5.35M sold.

Commonwealth Bank of Australia first reported a position in TMO in Q2 2013 and held it in 25 quarters. The position peaked at $18.9M in Q1 2014. 1,544 funds tracked by Wall St. Rank hold TMO as of Q3 2019.

  • Commonwealth Bank of Australia reported no remaining Thermo Fisher Scientific position as of Q3 2019 after selling out during the quarter.
  • Commonwealth Bank of Australia sold 18,229 Thermo Fisher Scientific shares in Q3 2019, an estimated $5.35M.
  • Commonwealth Bank of Australia first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 25 quarters.
  • Commonwealth Bank of Australia's Thermo Fisher Scientific position peaked at $18.9M in Q1 2014.
  • 1,544 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2019.

Based on Commonwealth Bank of Australia's 13F filing for Q3 2019.